Literature DB >> 25333615

Persistent production of an integrase-deleted HIV-1 variant with no resistance mutation and wild-type proviral DNA in a treated patient.

Mary-Anne Trabaud1, Laurent Cotte, Julien Saison, Christophe Ramière, Corinne Ronfort, Fabienne Venet, Jean-Claude Tardy, Guillaume Monneret, Patrice André.   

Abstract

An HIV-infected patient presenting an unexpected viral escape under combined antiretroviral treatment is described. The virus isolated from plasma contained a large deletion in the HIV-1 integrase gene but no known resistance mutation. Nested polymerase chain reactions (PCRs) with patient virus integrase-specific primers and probes were developed and used to detect the mutant from plasma, blood, rectal biopsies, and sperm. The variant progressively emerged during a period of therapy-induced virosuppression, and persisted at a low but detectable level for at least 5 years. Surprisingly, proviral DNA from lymphocytes, rectal cells, and sperm cells was, and remained, mainly wild type. Cellular HIV RNA with the deletion was detected only once from the rectum. The origin and mechanisms underlying this so far not described production at a detectable level are largely hypothetical. This observation raised concern about the ability of defective viruses to spread.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25333615      PMCID: PMC4287311          DOI: 10.1089/AID.2014.0129

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  30 in total

Review 1.  Anatomical basis of tolerance and immunity to intestinal antigens.

Authors:  Allan McI Mowat
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

Review 2.  HIV-1 replication.

Authors:  E O Freed
Journal:  Somat Cell Mol Genet       Date:  2001-11

3.  Homologous and nonhomologous retroviral recombinations are both involved in the transfer by infectious particles of defective avian leukosis virus-derived transcomplementing genomes.

Authors:  A Girod; A Drynda; F L Cosset; G Verdier; C Ronfort
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

4.  HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.

Authors:  J M Coffin
Journal:  Science       Date:  1995-01-27       Impact factor: 47.728

5.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

6.  Association between discordant immunological response to highly active anti-retroviral therapy, regulatory T cell percentage, immune cell activation and very low-level viraemia in HIV-infected patients.

Authors:  J Saison; T Ferry; J Demaret; D Maucort Boulch; F Venet; T Perpoint; F Ader; V Icard; C Chidiac; G Monneret
Journal:  Clin Exp Immunol       Date:  2014-06       Impact factor: 4.330

Review 7.  The importance of becoming double-stranded: Innate immunity and the kinetic model of HIV-1 central plus strand synthesis.

Authors:  Eric Poeschla
Journal:  Virology       Date:  2013-04-03       Impact factor: 3.616

8.  A soluble active mutant of HIV-1 integrase: involvement of both the core and carboxyl-terminal domains in multimerization.

Authors:  T M Jenkins; A Engelman; R Ghirlando; R Craigie
Journal:  J Biol Chem       Date:  1996-03-29       Impact factor: 5.157

9.  The HIV-1 reservoir in eight patients on long-term suppressive antiretroviral therapy is stable with few genetic changes over time.

Authors:  Lina Josefsson; Susanne von Stockenstrom; Nuno R Faria; Elizabeth Sinclair; Peter Bacchetti; Maudi Killian; Lorrie Epling; Alice Tan; Terence Ho; Philippe Lemey; Wei Shao; Peter W Hunt; Ma Somsouk; Will Wylie; Daniel C Douek; Lisa Loeb; Jeff Custer; Rebecca Hoh; Lauren Poole; Steven G Deeks; Frederick Hecht; Sarah Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-25       Impact factor: 11.205

10.  Replication-competent noninduced proviruses in the latent reservoir increase barrier to HIV-1 cure.

Authors:  Ya-Chi Ho; Liang Shan; Nina N Hosmane; Jeffrey Wang; Sarah B Laskey; Daniel I S Rosenbloom; Jun Lai; Joel N Blankson; Janet D Siliciano; Robert F Siliciano
Journal:  Cell       Date:  2013-10-24       Impact factor: 41.582

View more
  2 in total

1.  HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.

Authors:  Chi N Chan; Benjamin Trinité; Caroline S Lee; Saurabh Mahajan; Akanksha Anand; Dominik Wodarz; Steffanie Sabbaj; Anju Bansal; Paul A Goepfert; David N Levy
Journal:  Retrovirology       Date:  2016-01-05       Impact factor: 4.602

2.  Korean Red Ginseng increases defective pol gene in peripheral blood mononuclear cells of HIV-1-infected patients; inhibition of its detection during ginseng-based combination therapy.

Authors:  Young Keol Cho; Jung-Eun Kim; Jun-Hee Woo
Journal:  J Ginseng Res       Date:  2019-06-06       Impact factor: 6.060

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.